MELISSA FAIRBAIRN: Open Payments
NPI 1477609030 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 55 payments from 26 companies in 2025. Trend: 2023 $2,174 · 2024 $2,724 · 2025 $1,327
Food & beverage: $1,327
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $189 |
| Novartis Pharmaceuticals Corporation | 6 | $161 |
| AstraZeneca Pharmaceuticals LP | 5 | $153 |
| Incyte Corporation | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 3 | $76 |
| Genentech USA, Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Janssen Biotech, Inc. | 2 | $52 |
| SOBI, INC | 2 | $41 |
Products named: EPKINLY, OPDIVO, KISQALI, Fabhalta, TAGRISSO, Enhertu, DARZALEX, JAKAFI.
Industry payments across CT — which companies pay providers there.
